The IM peptide, in combination with L-arginine, exerts protective activity in epinephrine- and indomethacin-induced ulcers and gastric lesions in rats [4], where it decreases the activity of inducible nitric oxide synthase (iNOS) as well as the lipoperoxidation process in gastric mucosa. The gene discussed is NOS2; the disease is ulcer disease.